• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.27% Nasdaq Down0.19%

    Array BioPharma Inc. (ARRY)

    5.81 Up 0.12(2.11%) 4:00PM EDT
    |After Hours : 6.25 Up 0.44 (7.57%) 7:41PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Array BioPharma Inc.
    3200 Walnut Street
    Boulder, CO 80301
    United States - Map
    Phone: 303-381-6600
    Fax: 303-449-5376
    Website: http://www.arraybiopharma.com

    Index Membership:N/A
    Full Time Employees:198

    Business Summary 

    Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. The company’s products in Phase III clinical trials include Binimetinib and Encorafenib for the treatment of cancer. Its clinical programs in Phase II clinical trial include ARRY-797, a p38 program for Lamin A/C-related dilated cardiomyopathy; and ARRY-502, a CRTh2 antagonist to treat Th2-driven allergic disease. The company’s proprietary programs also comprise Filanesib, a kinesin spindle protein inhibitor for multiple myeloma; and ARRY-614, a p38/Tie2 dual inhibitor for myelodysplastic syndromes. Its partnered clinical programs include various drug candidates; Selumetinib, an MEK inhibitor for cancer; ASLAN001/ARRY-543, an HER2/EGFR inhibitor for gastric cancer; Ipatasertib/GDC-0068, an AKT inhibitor for cancer; VTX-2337, a toll-like receptor for cancer; and Danoprevir, a Hepatitis C virus protease inhibitor. The company’s partnered clinical programs also comprise LY2606368, an Chk-1 inhibitor for cancer; GDC-0575, an Chk-1 inhibitor for cancer; ARRY-380/ONT-380, an HER2 inhibitor for breast cancer,; GDC-0994, an ERK inhibitor for cancer; and LOXO-101, an PanTrk inhibitor for cancer. It has collaborations with Celgene Corporation; Celgene Alpine Investment Co., LLC; Genentech, Inc.; Loxo Oncology, Inc; Novartis International Pharmaceutical Ltd.; and Oncothyreon Inc. The company was founded in 1998 and is headquartered in Boulder, Colorado.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Array BioPharma Inc.

    Corporate Governance 
    Array BioPharma Inc.’s ISS Governance QuickScore as of Jul 1, 2015 is 8. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 8; Compensation: 9.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Ron Squarer BSc (Biochemistry), MBA, 48
    Chief Exec. Officer and Director
    Mr. Andrew Robbins ,
    Chief Operating Officer
    Dr. Nicholas A. Saccomano Ph.D., 56
    Chief Scientific Officer
    Mr. John R. Moore , 51
    VP, Gen. Counsel and Sec.
    Dr. Victor Sandor M.D., C.M,
    Chief Medical Officer
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders